The binding of CLL B cells to stromal cells requires simultaneous action of β1 integrin (ITGB1, also known as CD29) and β2 integrin (ITGB2, also known as CD18) (72, 73). Here, ITGB1 is linked to B-cell chronic lymphocytic leukemia.